Income Statement (TTM)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29,460 | 30,307 | 32,483 | 33,231 | 35,253 | 39,011 | 41,340 | 43,406 | 43,586 | 43,952 | 44,437 | 43,999 | 43,029 | 41,400 | 40,686 | 40,467 | 41,611 | 41,067 | 40,330 | 40,119 |
| Change (%) | 2.87 | 7.18 | 2.30 | 6.08 | 10.66 | 5.97 | 5.00 | 0.41 | 0.84 | 1.11 | -0.99 | -2.21 | -3.79 | -1.72 | -0.54 | 2.83 | -1.31 | -1.79 | -0.52 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 12,774 | 13,798 | 15,044 | 15,856 | 17,680 | 20,294 | 22,272 | 23,628 | 23,571 | 23,256 | 22,689 | 22,369 | 22,123 | 21,717 | 21,500 | 21,479 | 21,827 | 21,426 | 21,269 | 21,087 |
| Change (%) | 8.02 | 9.03 | 5.40 | 11.50 | 14.79 | 9.74 | 6.09 | -0.24 | -1.33 | -2.44 | -1.41 | -1.10 | -1.84 | -1.00 | -0.10 | 1.62 | -1.84 | -0.73 | -0.85 | |
| % of Revenue | 43.36 | 45.53 | 46.31 | 47.72 | 50.15 | 52.02 | 53.88 | 54.44 | 54.08 | 52.91 | 51.06 | 50.84 | 51.41 | 52.46 | 52.84 | 53.08 | 52.45 | 52.17 | 52.74 | 52.56 |
| Gross Operating Profit | 16,687 | 16,509 | 17,439 | 17,375 | 17,573 | 18,717 | 19,068 | 19,778 | 20,015 | 20,696 | 21,749 | 21,630 | 20,906 | 19,683 | 19,187 | 18,988 | 19,785 | 19,641 | 19,062 | 19,032 |
| Change (%) | -1.06 | 5.63 | -0.37 | 1.14 | 6.51 | 1.88 | 3.72 | 1.20 | 3.40 | 5.09 | -0.54 | -3.35 | -5.85 | -2.52 | -1.03 | 4.19 | -0.72 | -2.95 | -0.16 | |
| % of Revenue | 56.64 | 54.47 | 53.69 | 52.28 | 49.85 | 47.98 | 46.12 | 45.56 | 45.92 | 47.09 | 48.94 | 49.16 | 48.59 | 47.54 | 47.16 | 46.92 | 47.55 | 47.83 | 47.26 | 47.44 |
| SG&A | 11,628 | 11,204 | 11,682 | 11,636 | 11,695 | 12,401 | 12,514 | 12,585 | 12,730 | 13,061 | 13,714 | 14,358 | 14,379 | 14,198 | 13,938 | 13,393 | 13,512 | 13,071 | 12,921 | 12,969 |
| Change (%) | -3.65 | 4.27 | -0.40 | 0.50 | 6.04 | 0.91 | 0.57 | 1.16 | 2.60 | 4.99 | 4.70 | 0.15 | -1.26 | -1.83 | -3.91 | 0.89 | -3.26 | -1.14 | 0.37 | |
| % of Revenue | 39.47 | 36.97 | 35.96 | 35.01 | 33.17 | 31.79 | 30.27 | 28.99 | 29.21 | 29.72 | 30.86 | 32.63 | 33.42 | 34.29 | 34.26 | 33.10 | 32.47 | 31.83 | 32.04 | 32.33 |
| R&D | 2,629 | 2,795 | 2,944 | 3,153 | 3,332 | 3,837 | 4,006 | 4,103 | 4,286 | 4,302 | 4,461 | 4,609 | 4,595 | 4,346 | 4,207 | 4,074 | 3,839 | 3,644 | 3,552 | 3,499 |
| Change (%) | 6.33 | 5.30 | 7.11 | 5.67 | 15.18 | 4.40 | 2.41 | 4.48 | 0.37 | 3.70 | 3.32 | -0.32 | -5.41 | -3.21 | -3.17 | -5.76 | -5.07 | -2.53 | -1.49 | |
| % of Revenue | 8.92 | 9.22 | 9.06 | 9.49 | 9.45 | 9.84 | 9.69 | 9.45 | 9.83 | 9.79 | 10.04 | 10.48 | 10.68 | 10.50 | 10.34 | 10.07 | 9.23 | 8.87 | 8.81 | 8.72 |
| OpEx | 27,039 | 27,689 | 29,599 | 30,581 | 32,675 | 36,474 | 38,726 | 40,282 | 40,453 | 40,531 | 40,777 | 41,172 | 40,985 | 40,215 | 39,606 | 38,981 | 39,144 | 38,093 | 37,689 | 37,553 |
| Change (%) | 2.40 | 6.90 | 3.32 | 6.85 | 11.63 | 6.17 | 4.02 | 0.42 | 0.20 | 0.61 | 0.97 | -0.45 | -1.88 | -1.52 | -1.58 | 0.42 | -2.69 | -1.06 | -0.36 | |
| % of Revenue | 91.78 | 91.36 | 91.12 | 92.03 | 92.69 | 93.50 | 93.68 | 92.80 | 92.81 | 92.22 | 91.76 | 93.57 | 95.25 | 97.14 | 97.34 | 96.33 | 94.07 | 92.76 | 93.45 | 93.60 |
| Operating Income | 2,421 | 2,618 | 2,883 | 2,650 | 2,578 | 2,537 | 2,614 | 3,124 | 3,133 | 3,420 | 3,660 | 2,827 | 2,044 | 1,184 | 1,080 | 1,486 | 2,467 | 2,974 | 2,641 | 2,566 |
| Change (%) | 8.12 | 10.13 | -8.09 | -2.73 | -1.59 | 3.03 | 19.53 | 0.29 | 9.16 | 7.02 | -22.76 | -27.71 | -42.05 | -8.78 | 37.54 | 66.01 | 20.55 | -11.19 | -2.84 | |
| % of Revenue | 8.22 | 8.64 | 8.88 | 7.97 | 7.31 | 6.50 | 6.32 | 7.20 | 7.19 | 7.78 | 8.24 | 6.43 | 4.75 | 2.86 | 2.66 | 3.67 | 5.93 | 7.24 | 6.55 | 6.40 |
| Interest Expense | -898 | -881 | -863 | -874 | -876 | -823 | -825 | -841 | -889 | -964 | -1,042 | -1,128 | -1,213 | -1,325 | -1,388 | -1,431 | -1,445 | -1,432 | -1,413 | -1,375 |
| Change (%) | -1.86 | -2.00 | 1.22 | 0.23 | -6.08 | 0.26 | 1.95 | 5.76 | 8.40 | 8.08 | 8.32 | 7.49 | 9.24 | 4.76 | 3.10 | 0.98 | -0.91 | -1.30 | -2.70 | |
| % of Revenue | -3.05 | -2.91 | -2.66 | -2.63 | -2.48 | -2.11 | -1.99 | -1.94 | -2.04 | -2.19 | -2.34 | -2.56 | -2.82 | -3.20 | -3.41 | -3.54 | -3.47 | -3.49 | -3.50 | -3.43 |
| Net Income | 3,737 | 3,663 | 3,933 | 4,430 | 4,749 | 4,729 | 4,338 | 3,782 | 3,600 | 3,731 | 4,261 | 3,973 | 3,578 | 2,386 | 2,009 | 1,834 | 2,114 | 2,770 | 2,925 | 3,247 |
| Change (%) | -1.98 | 7.37 | 12.65 | 7.18 | -0.42 | -8.26 | -12.82 | -4.81 | 3.63 | 14.22 | -6.77 | -9.94 | -33.30 | -15.81 | -8.73 | 15.28 | 31.04 | 5.60 | 11.01 | |
| % of Revenue | 12.68 | 12.09 | 12.11 | 13.33 | 13.47 | 12.12 | 10.49 | 8.71 | 8.26 | 8.49 | 9.59 | 9.03 | 8.31 | 5.76 | 4.94 | 4.53 | 5.08 | 6.74 | 7.25 | 8.09 |
Source: Capital IQ
